Company BioCardia Inc Nasdaq
Equities
US09060U1016
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-21 | BioCardia to Implement 1-for-15 Reverse Stock Split; Shares Fall After Hours | MT |
05-14 | Transcript : BioCardia, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -64.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 31/12/01 |
David McClung
DFI | Director of Finance/CFO | 61 | 31/08/13 |
Chief Tech/Sci/R&D Officer | - | 31/07/17 | |
Sujith Shetty
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/19 |
Ian McNiece
CTO | Chief Tech/Sci/R&D Officer | 70 | 07/11/17 |
Anne Laluc
IRO | Public Communications Contact | - | - |
Mark Schwartz
PRN | Corporate Officer/Principal | - | 31/10/18 |
Edward Gillis
PRN | Corporate Officer/Principal | 62 | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 31/12/01 |
Jay Moyes
BRD | Director/Board Member | 70 | 31/12/10 |
Richard Krasno
BRD | Director/Board Member | 82 | 23/10/16 |
Director/Board Member | 53 | 17/10/23 | |
Peter Altman
CEO | Chief Executive Officer | 57 | 31/12/01 |
Andrew Blank
CHM | Chairman | 68 | 30/09/19 |
Jim Allen
BRD | Director/Board Member | 69 | 30/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,304,116 | 19,255,345 ( 70.52 %) | 0 | 70.52 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.93% | 21.97B | |
-5.71% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BCDA Stock
- Stock
- Company BioCardia Inc